Persistent hypofibrinolysis in severe COVID-19 associated with elevated fibrinolysis inhibitors activity
Hypercoagulability and reduced fibrinolysis are well-established complications associated with COVID-19. However, the timelines for the onset and resolution of these complications remain unclear. The aim of this study was to evaluate, in a cohort of COVID-19 patients, changes in coagulation and fibr...
Gespeichert in:
Veröffentlicht in: | Journal of thrombosis and thrombolysis 2024-04, Vol.57 (4), p.721-729 |
---|---|
Hauptverfasser: | , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!